Search hospitals > Colorado > Pueblo
Rocky Mountain Cancer Centers - Pueblo
Claim this profilePueblo, Colorado 81008
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
131 reported clinical trials
5 medical researchers
Summary
Rocky Mountain Cancer Centers - Pueblo is a medical facility located in Pueblo, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers - Pueblo is involved with conducting 131 clinical trials across 347 conditions. There are 5 research doctors associated with this hospital, such as Richard L. Deming, Robert M. Jotte, Sami Diab, and Mehmet S. Copur.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Robert M. JotteGSK Investigational Site3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
11 drugs studied
Sami DiabRocky Mountain Cancer Centers7 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
5 reported clinical trials
11 drugs studied
Mehmet S. CopurBethesda North Hospital12 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
2 reported clinical trials
8 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers - Pueblo
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Cancer
Laryngeal Cancer
Germ Cell Tumors
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers - Pueblo?
Rocky Mountain Cancer Centers - Pueblo is a medical facility located in Pueblo, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers - Pueblo is involved with conducting 131 clinical trials across 347 conditions. There are 5 research doctors associated with this hospital, such as Richard L. Deming, Robert M. Jotte, Sami Diab, and Mehmet S. Copur.